Skip to main content

Webinar: Natural language processing innovations for drug safety in Pharma

When:

Time: 8:00am PDT, 11:00am EDT, 4:00pm BST, 5:00pm CEST

Duration: 60 minutes


ACCESS RECORDING

Drug safety is of critical importance, at all stages in drug discovery, development and delivery. Across the whole span, safety-relevant data is being both generated and sought from unstructured text – from internal safety reports, scientific literature, individual case safety reports, clinical investigator brochures, patient forums, social media, conference abstracts. 

Intelligent search across these hundreds of thousands of pages can provide the information for key decision support. Life science companies are actively pursuing innovative technologies to address the challenge of managing increasing volumes of safety-related data from new and disparate sources.  Many of our customers are using the power of Linguamatics Natural Language Processing (NLP) platform to transform the unstructured text into actionable structured data that can be rapidly visualized and analyzed, at every stage through the safety lifecycle of a drug. This webinar will present an overview of customer success stories, to show best practice use of this Artificial Intelligence (AI) technology to advance drug safety. 

What will you learn? 

  • How natural language processing (NLP) text mining can extract structured data from unstructured text in scientific papers, clinical trial databases, internal safety reports, FDA drug labels, and more. 
  • How big pharma access internal data silos and external data sources for safety decision making. Use cases from top pharma and the FDA will be discussed.  

Who should attend? 

  • Anyone with an interest in getting better value from both internal and external textual information and integrating diverse data sets to provide knowledge relevant to drug safety and risk prediction. 
  • Specifically, informaticians, information professionals, researchers, with responsibility for: 
  • Risk profiles for targets in early drug discovery 
  • Preclinical and clinical drug safety 
  • Safety assessment across the pipeline

 

Speakers

Jane Reed - Director, Life Science
Jane Reed
Director, Life Science
Kaitlyn Whyte Linguamatics Application Scientist
Kaitlyn Whyte
Linguamatics Application Scientist

Ready to get started?

Request a Demo

Questions? Ask our experts